Clinical Trials Sponsored by China National Center for Cardiovascular Diseases

Total 981 results

Peking University Third Hospital
Centers for Disease Control and Prevention, China

Completed

Evaluation of Diagnostic Criteria for Creutzfeldt Jakob Disease

Creutzfeldt Jakob Disease
Sinovac Biotech Co., Ltd
Centers for Disease Control and Prevention, China

Completed

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents

Influenza

China
Jiangsu Province Centers for Disease Control and...
West China Hospital

Completed

Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)

COVID-19

China
Jiangsu Province Centers for Disease Control and...
West China Hospital

Withdrawn

Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)

COVID-19

China
Centers for Disease Control and Prevention, China
Merck Sharp & Dohme LLC

Unknown

A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance

HIV Infections | HIV

China
Sinovac Biotech Co., Ltd
Centers for Disease Control and Prevention, China

Completed

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children

Influenza

China
Sinovac Biotech Co., Ltd
Centers for Disease Control and Prevention, China

Completed

Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine

Prevention | Pandemic Influenza
Beijing Children's Hospital
Centers for Disease Control and Prevention, China; Capital Institute of Pediatrics...

Not yet recruiting

Real World App-based CCAAP Management of Children With Asthma

Asthma
German Cancer Research Center
University Hospital Heidelberg; National Center for Tumor Diseases, Heidelberg

Completed

Prevention of Chemotherapy-Related Polyneuropathy Via Sensorimotor Exercise Training (PIC)

Exercise | Chemotherapy-induced Polyneuropathy

Germany
German Cancer Research Center
University Hospital Heidelberg; National Center for Tumor Diseases, Heidelberg

Completed

POSITIVE - Study (Part III) Heidelberg (POSITIVE)

Advanced NSCLC | First Line Treatment

Germany
German Cancer Research Center
University Hospital Heidelberg; National Center for Tumor Diseases, Heidelberg

Completed

Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy (BEST)

Breast Cancer | Cancer-related Fatigue

Germany
National Center for Chronic and Noncommunicable...
World Health Organization

Enrolling by invitation

Implementation of a Comprehensive Intervention on Hypertension（HTN） and Type 2 Diabetes Mellitus（DM） at PHC Level

Hypertension | Diabetes Mellitus, Type 2

China
University Hospital Heidelberg
National Center for Tumor Diseases, Heidelberg

Completed

TEAM-Trial: Targeting Epigenetic Therapy Resistance in AML With Bortezomib (TEAM)

Acute Myeloid Leukemia

Germany
National Center for Tumor Diseases, Heidelberg
University Hospital Heidelberg

Completed

CCR5-blockade in Metastatic Colorectal Cancer (MARACON)

Neoplasm Metastasis | Colorectal Cancer | Liver Metastases

Germany
National Center for AIDS/STD Control and Prevention...

Completed

Chinese Network of Pediatric Antiretroviral Therapy (CN-PART)

Acquired Immunodeficiency Syndrome

China
National Center for Tumor Diseases, Heidelberg
German Cancer Research Center; University Hospital Heidelberg

Terminated

Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer (ATACC)

Colorectal Carcinoma

Germany
German Cancer Research Center
University Hospital Heidelberg; National Center for Tumor Diseases, Heidelberg

Recruiting

PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers (PANHPVAX)

HPV

Germany
National Center for AIDS/STD Control and Prevention...

Completed

Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission

HIV

China
National Center for AIDS/STD Control and Prevention...

Unknown

Using HIV Risk Assessment Tool to Promote HIV Testing Among Men Who Have Sex With Men (online-RASSL)

HIV Infections | HIV/AIDS | Social Media

China
National Center for AIDS/STD Control and Prevention...

Completed

Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)

AIDS

China
Beijing Chest Hospital
National Medical Center for Infectious Diseases

Recruiting

Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort (INSPIRE-CODA)

Pulmonary Tuberculosis | Rifampicin-resistant Tuberculosis

China
University Hospital Tuebingen
National Center for Tumor Diseases, Heidelberg

Completed

WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data (NF2)

Neurofibromatosis Type 2 | Vestibular Schwannoma | Acoustic Neuroma

Germany
National Center for Tumor Diseases, Heidelberg
University Hospital Heidelberg

Completed

Ipilimumab in Patients With Advanced Melanoma and Spontaneous Preexisting Immune Response to NY-ESO-1 (CTLA4 NY-ESO-1)

Metastatic Melanoma

Germany
Yale University
National Institute on Drug Abuse (NIDA); Centers for Disease Control and Prevention...

Completed

Behavioral Drug and HIV Risk Reduction Counseling With MMT in China

Opiate Dependence

China
National Institute of Allergy and Infectious Diseases...
Centers for Disease Control and Prevention

Completed

Rapid HIV Testing for Emergency Department Patients

HIV Infections

United States
National University, Singapore
National Centre for Infectious Diseases, Singapore; Action for AIDS Singapore

Completed

The People Like Us Evaluation Study

HIV/AIDS | Health Behavior | Stigma, Social | Sexually Transmitted Infection | Homosexuality | Health Care Seeking Behavior

Singapore
China National Center for Cardiovascular Diseases
Peking University International Hospital; Beijing Shijitan Hospital, Capital... and other collaborators

Not yet recruiting

Complete Revascularization Via Inferior Part-sternotomy

Multivessel Coronary Artery Disease | Coronary Artery Bypass Grafting | Complete Revascularization
University of California, Los Angeles
Centers for Disease Control and Prevention, China

Completed

Methadone Maintenance and HIV Prevention: A Window of Opportunity in China (MMT1)

HIV/AIDS | Drug Use | Capacity Building

China
University of California, Los Angeles
Centers for Disease Control and Prevention, China

Completed

POL and Access Intervention to Reduce HIV Stigma Among Service Providers in China

Patient Satisfaction | HIV-related Stigma | Provider-patient Interaction

United States
Suping Wang
Centers for Disease Control and Prevention, China

Completed

Immunogenicity of Hepatitis B Vaccination in HIV-infected Adults (HIV)

Hepatitis B Vaccine
Suping Wang
Centers for Disease Control and Prevention, China

Completed

Immunogenicity of Hepatitis B Vaccination in Hemodialysis Patients

Hepatitis B Vaccine
Centers for Disease Control and Prevention, China
Shanghai Institute Of Biological Products

Completed

A Post-marketing Safety Study of Inactivated, Split-virion Influenza Vaccine in Subjects Aged 3 Years and Older

Influenza | Vaccination Adverse Event
West China Hospital
Beijing Tiantan Hospital; First Affiliated Hospital of Chongqing Medical University and other collaborators

Completed

Effects of Message Framing and Time Discounting on Health Communication for Optimum Cardiovascular Disease and Stroke Prevention (EMT-OCSP)

Stroke | Cardiovascular Disease | Primary Prevention

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Hunan Provincial Center for... and other collaborators

Completed

Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes

COVID-19 Pneumonia

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Hunan Provincial Center for... and other collaborators

Not yet recruiting

Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes

COVID-19 Pneumonia

China
China National Biotec Group Company Limited
Wuhan Institute of Biological Products Co., Ltd; Hunan Provincial Center for... and other collaborators

Not yet recruiting

Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes

COVID-19 Pneumonia

China
National Cerebral and Cardiovascular Center, Japan
Japan Agency for Medical Research and Development

Completed

The Bleeding With Antithrombotic Therapy Study 2 (BAT2)

Cerebrovascular and Cardiovascular Diseases

Japan
China National Biotec Group Company Limited
Wuhan Institute of Biological Products Co., Ltd; Hunan Provincial Center for... and other collaborators

Not yet recruiting

Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes

COVID-19 Pneumonia

China
University of California, San Francisco
Jiangsu Provincial Center for Diseases Control and Prevention, China

Terminated

Development of an HIV Self-testing Intervention

HIV Serosorting

China
University of Ulm
Pfizer; National Center for Tumor Diseases, Heidelberg

Unknown

Study of Palbociclib in MLL-rearranged Acute Leukemias

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia

Germany
National Center for Tumor Diseases, Heidelberg
Heidelberg University; iOMEDICO AG

Unknown

Effects of ECA on Quality of Life in Head and Neck Cancer Patients Suffering From Cetuximab-induced Rhagades (SUPPORT)

Pain

Germany
National Institute for Communicable Diseases, South...
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention

Unknown

Effectiveness of Trivalent Inactivated Influenza Maternal Vaccination Among Pregnant Women and Their Newborns in South Africa

Influenza Viral Infections

South Africa
Technische Universität Dresden
German Cancer Research Center; National Center for Tumor Diseases, Heidelberg; Radiation Oncology Working Group of the German Cancer Society and other collaborators

Recruiting

De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas (DELPHI)

Head-and-neck Squamous Cell Carcinoma

Germany
National Opinion Research Center
Centers for Disease Control and Prevention; Emory Healthcare

Completed

Evaluating the Cost Effectiveness of STEADI (STEADI)

Accidental Fall

United States
Centre for Infectious Disease Research in Zambia
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Causes of Rotavirus Vaccine Failure in Zambian Children

Diarrhoea

Zambia
University Hospital, Angers
National Center for Spatial Study, Toulouse; Astronaut Center of China

Completed

CARDIOSPACE Evaluation in Healthy Volunteers (CARDIOSPACE)

Healthy

France
Shaochun.Li
Beijing Friendship Hospital; Peking University Third Hospital; Xuanwu Hospital... and other collaborators

Unknown

Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)

Dyslipidemia | Subclinical hypothyroïdism | ASCVD | Statin

China
University of Khartoum
National Center for Kidney Diseases and Surgery

Recruiting

Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation

Kidney Transplant Rejection

Sudan
National Center for Tumor Diseases, Heidelberg
Pfizer; Roche Pharma AG

Terminated

Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy (APRIORI)

Colorectal Carcinoma

Germany
University Hospital Heidelberg
German Cancer Research Center; National Center for Tumor Diseases, Heidelberg; German Cancer Aid

Completed

NCT Neuro Master Match - N²M² (NOA-20) (N²M²)

Glioblastoma, Adult

Germany

Clinical Trials Sponsored by China National Center for Cardiovascular Diseases

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations